Detailed Narrative
Strong Q1 Performance and Outlook
Zurn Elkay reported 11% organic sales growth and 18% adjusted EBITDA growth to $116 million, with margins expanding 160 basis points to 26.8%. The company's Q1 results and Q2 guidance (8-9% core sales growth, 27-27.5% adjusted EBITDA margin) are ahead of initial expectations for the first half of 2026. Management indicated this outperformance will flow through to the full year, with a formal update planned after Q2 results.
Tariff Environment Management
The company is actively managing a complex tariff landscape, including Supreme Court rulings, 122/232 tariff changes, and new 301 tariff studies. Management expressed high confidence that the discrete impact of tariffs in 2026 will remain price/cost positive, even without future price increases or tariff refunds. This confidence stems from supply chain footprint initiatives, product substitution, and the fact that the U.S. is now their largest sourcing country.
Strategic Mix Shift and Resilience
Zurn Elkay has intentionally shifted its product mix, with retrofit/replace now evenly split at 50% (up from 45% five years ago) due to growth in drinking water, filtration, and water/safety control products. This shift is expected to enhance business resilience and contribute positively to margin mix over time⏳. The company targets a further increase to 55% retrofit/replace in the coming years.
EBITDA Margin Expansion Drivers
Over the last 13 quarters, adjusted EBITDA margins have improved 730 basis points, reaching 26.8% in Q1 FY26 from 19.5% in Q1 2023. This expansion is attributed to the Zurn Elkay Business System, continuous improvement initiatives (#CI), unit volume growth in profitable areas (Water Safety and Control, Flow Systems, Drinking Water), structural changes post-Elkay merger, and a competitive supply chain.
Capital Allocation and M&A Strategy
The company ended the quarter with a net debt leverage of 0.5x, inclusive of $50 million in share repurchases. The revolver was upsized to $550 million, enhancing liquidity. Management maintains a disciplined M&A funnel, cultivating targets rather than participating in auctions, and focusing on strategic fit and return hurdles. Capital allocation priorities remain share buybacks (when intrinsic value is understated) and dividends.
New Product Development and Growth Adjacencies
Zurn Elkay is making great progress on new product introductions and entering growth adjacencies, which are expected to open additional available market. These initiatives are anticipated to be additive to long-term growth rates and provide resilience against potential market slowdown🌐s. More details on these developments are expected to be shared by Q3 and into Q4 and early next year.